Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Endocrinology & Metabolism|February 24, 2023
Genotype-phenotype correlations in Graves' diseaseMikołaj Radziszewski, Aleksander Kuś, Tomasz Bednarczuk
The Journal of Clinical Endocrinology and Metabolism|April 10, 2020
The Genetic Basis of Thyroid Function: Novel Findings and New ApproachesAleksander Kuś, Layal Chaker, Alexander Teumer, et al.
Endokrynologia Polska|March 18, 2024
Long-term remission of corticosteroid-resistant Graves' orbitopathy after therapy with tocilizumabJoanna Rymuza, Aleksander Kuś, Dorota Białas-Niedziela, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2023
Height, Autoimmune Thyroid Disease, and Thyroid Cancer: A Mendelian Randomization StudyAreti Papadopoulou, Bjørn O Åsvold, Stephen Burgess, et al.
Human Molecular Genetics|February 28, 2022
Thyroid function, pernicious anemia and erythropoiesis: a two-sample Mendelian randomization studyAlisa D Kjaergaard, Alexander Teumer, Eirini Marouli, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2025
Genetics of Thyroid Function: Relevance for Biology and Disease ManagementRosalie B T M Sterenborg, Robin P Peeters, Edward Visser, et al.
Thyroid : Official Journal of the American Thyroid Association|August 5, 2020
Variation in Normal Range Thyroid Function Affects Serum Cholesterol Levels, Blood Pressure, and Type 2 Diabetes Risk: A Mendelian Randomization StudyAleksander Kuś, Eirini Marouli, Fabiola Del Greco M, et al.
Clinical Endocrinology|May 13, 2014
Increased concentration of T-cell receptor rearrangement excision circles (TREC) in peripheral blood in Graves' diseaseKatarzyna Strawa, Anna Markowska, Piotr Miśkiewicz, et al.
Clinical Endocrinology|October 28, 2014
The association of thyroid peroxidase antibody risk loci with susceptibility to and phenotype of Graves' diseaseAleksander Kuś, Konrad Szymański, Robin P Peeters, et al.
Thyroid : Official Journal of the American Thyroid Association|May 12, 2026
Tocilizumab in Active, Moderate-to-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: An Open-Label Prospective Study in Two Independent CohortsJoanna Rymuza, Aleksander Kuś, Biljana Nedeljković Beleslin, et al.
Pageof 3